Step-up hemostasis strategy for endoscopic sphincterotomy bleeding using a novel self-assembling peptide (STOP trial)

Step-up hemostasis strategy for endoscopic sphincterotomy bleeding using a novel self-assembling peptide (STOP trial) - Step-up hemostasis strategy for endoscopic sphincterotomy bleeding using a novel self-assembling peptide (STOP trial)

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000048983

Enrollment

Registered

2022-10-01

Start date

2022-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bleeding after EST

Interventions

Self-assembling peptide hemostatic gel as a first-line endoscopic hemostasis technique for bleeding after EST

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: 1. Bleeding after EST 2. Age from 20 years to 90 years old 3. Obtaining informed consent

Exclusion criteria

Exclusion criteria: 1. Surgical altered anatomy 2. ASA 3 or over 3. ECOG PS 4 4. survival time under 3 months 5. inadequate inclusion, which is decided by attending doctors

Design outcomes

Primary

Measure	Time frame
The technical success rate for hemostasis	—

Countries

Japan

Contacts

Public ContactTakeshi Ogura

Osaka Medical and Pharmaceutical University 2nd Department of Internal Medicine

oguratakeshi0411@yahoo.co.jp072-683-1221

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026